Abstract

In the sympathetic nervous system, ATP is a co-transmitter and modulator of transmitter release, inhibiting noradrenaline release by acting on P2Y autoreceptors, but in peripheral tissues the subtypes involved have only scarcely been identified. We investigated the identity of the noradrenaline release-inhibiting P2Y subtypes in the epididymal portion of vas deferens and tail artery of the rat. The subtypes operating as autoreceptors, the signalling mechanism and cross-talk with α 2-autoreceptors, was also investigated in the epididymal portion. In both tissues, the nucleotides 2-methylthioATP, 2-methylthioADP, ADP and ATP inhibited noradrenaline release up to 68%, with the following order of potency: 2-methylthioADP = 2-methylthioATP > ADP = ATP in the epididymal portion and 2-methylthioADP = 2-methylthioATP = ADP > ATP in the tail artery. The selective P2Y 1 antagonist 2′-deoxy-N 6-methyladenosine 3′,5′-bisphosphate (30 μM) and the P2Y 12 antagonist 2,2-dimethyl-propionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethyl-propionyloxymethyl)-propyl ester (30 μM) increased noradrenaline release per se by 25 ± 8% and 18 ± 3%, respectively, in the epididymal portion but not in tail artery. Both antagonists attenuated the effect of nucleotides in the epididymal portion whereas in tail artery only the P2Y 1 antagonist was effective. The agonist of P2Y 1 and P2Y 12 receptors, 2-methylthioADP, caused an inhibition of noradrenaline release that was not prevented by inhibition of phospholipase C or protein kinase C but was abolished by pertussis toxin. 2-methylthioADP and the adenosine A 1 receptor agonist N 6-cyclopentyladenosine were less potent at inhibiting noradrenaline release under marked influence of α 2-autoinhibition. In both tissues, nucleotides modulate noradrenaline release by activation of inhibitory P2Y 1 receptors but in the epididymal portion P2Y 12 receptors also participate. P2Y 1 and P2Y 12 receptors are coupled to G i/o-proteins and operate as autoreceptors in the vas deferens where they interact with α 2-adrenoceptors on the modulation of noradrenaline release.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.